Latest Articles
Mali Barbi, MD, MS, on Endometrial Cancer: Data in dMMR Disease and B7-H4 ADCs for Advanced Disease - The ASCO Post
Mali Barbi, MD, MS, on Endometrial Cancer: Data in dMMR Disease and B7-H4 ADCs for Advanced Disease The ASCO Post
Published: June 8, 2026, 4:29 p.m.
Push for 12 days reproductive health leave as Australians forced to choose between work and treatment - 7NEWS
Push for 12 days reproductive health leave as Australians forced to choose between work and treatment 7NEWS
Published: June 6, 2026, 10:55 a.m.
The free exhibition that makes visible the silenced pain of endometriosis - Foro3D
The free exhibition that makes visible the silenced pain of endometriosis Foro3D
Published: June 3, 2026, 8:16 p.m.
At 85, she faced two tumours and a life-threatening blockage: How one high-risk surgery changed everything - MSN
At 85, she faced two tumours and a life-threatening blockage: How one high-risk surgery changed everything MSN
Published: June 3, 2026, 3:49 p.m.
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post
Published: June 3, 2026, 2:49 p.m.
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer - Oncodaily
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer Oncodaily
Published: June 3, 2026, 3:15 a.m.
Pancreatic cancer breakthrough: New daily pill nearly doubles survival time in advanced patients - TheHealthSite
Pancreatic cancer breakthrough: New daily pill nearly doubles survival time in advanced patients TheHealthSite
Published: June 2, 2026, 10:11 a.m.
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - MSN
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer MSN
Published: June 2, 2026, 12:41 a.m.
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - Medical Xpress
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer Medical Xpress
Published: June 1, 2026, 8 p.m.
'I had never experienced pain like it': Why it is time we stopped telling women that agony is normal - MSN
'I had never experienced pain like it': Why it is time we stopped telling women that agony is normal MSN
Published: June 1, 2026, 7:50 a.m.
Link copied to clipboard!